لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Castiello L; Istituto Pasteur Italia-Cenci Bolognetti Foundation, Viale Regina Elena 291, 00161, Rome, Italy. luciano.castiello@iss.it.; FaBioCell, Core Facilities, Istituto Superiore di Sanità, Rome, Italy. luciano.castiello@iss.it., Zevini A; Istituto Pasteur Italia-Cenci Bolognetti Foundation, Viale Regina Elena 291, 00161, Rome, Italy., Vulpis E; Department of Molecular Medicine, Sapienza University, Rome, Italy., Muscolini M; Istituto Pasteur Italia-Cenci Bolognetti Foundation, Viale Regina Elena 291, 00161, Rome, Italy., Ferrari M; Istituto Pasteur Italia-Cenci Bolognetti Foundation, Viale Regina Elena 291, 00161, Rome, Italy., Palermo E; Istituto Pasteur Italia-Cenci Bolognetti Foundation, Viale Regina Elena 291, 00161, Rome, Italy., Peruzzi G; Center for Life Nano Science@Sapienza, Istituto Italiano di Tecnologia, Rome, Italy., Krapp C; Department of Biomedicine, Aarhus University, Aarhus, Denmark., Jakobsen M; Department of Biomedicine, Aarhus University, Aarhus, Denmark., Olagnier D; Department of Biomedicine, Aarhus University, Aarhus, Denmark., Zingoni A; Department of Molecular Medicine, Sapienza University, Rome, Italy., Santoni A; Istituto Pasteur Italia-Cenci Bolognetti Foundation, Viale Regina Elena 291, 00161, Rome, Italy.; Department of Molecular Medicine, Sapienza University, Rome, Italy., Hiscott J; Istituto Pasteur Italia-Cenci Bolognetti Foundation, Viale Regina Elena 291, 00161, Rome, Italy. john.hiscott@istitutopasteur.it.

المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2019 Sep; Vol. 68 (9), pp. 1479-1492. Date of Electronic Publication: 2019 Aug 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*therapeutic use , Dendritic Cells/*immunology , Melanoma/*drug therapy , Nelfinavir/*analogs & derivatives, Alarmins/immunology ; Antigen Presentation/drug effects ; Antineoplastic Agents/pharmacology ; Apoptosis/drug effects ; Apoptosis Regulatory Proteins/metabolism ; Calreticulin/metabolism ; Caspase 3/metabolism ; Cell Differentiation ; Cell Line, Tumor ; DEAD Box Protein 58/antagonists & inhibitors ; HMGB1 Protein/metabolism ; Humans ; Immunization ; Interferons/metabolism ; Molecular Targeted Therapy ; Nelfinavir/pharmacology ; Nelfinavir/therapeutic use ; Proto-Oncogene Proteins/metabolism ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Receptors, Immunologic ; Signal Transduction